Cannabis Suisse Corp (CSUI) reported a nominal quarterly revenue of $7,500 for QQ3 2024, accompanied by a substantial loss and a severely strained liquidity position. The company posted a net loss of $67,974 and an EBITDA of negative $61,800, with gross profit turning negative at -$437 and a gross margin of -5.83%. Operating income registered -$62,861 and the net income margin stood at -9.06% on the quarter. Cash flow from operations was deeply negative at -$23,430, and free cash flow matched the operating cash burn. The balance sheet reveals a highly leveraged structure with total assets of $525.9 million but total liabilities of $1,002.9 million and negative stockholders’ equity of -$476.98 million, signaling material solvency risk despite a large fixed asset base (PPE of $525.9 million).
The QQ3 2024 result set underscores a fragile near-term financial position, with limited liquidity (current and quick ratios effectively near zero) and a substantial debt load (long-term debt of $593.0 million and total debt of $916.7 million). Management commentary is not provided in the supplied transcript data, limiting insight into strategic pivots or forward-looking guidance. Absent a material improvement in revenue generation or a decisive balance-sheet recapitalization, CSUI faces a prolonged earnings-and-liquidity runway challenge.